(EXC) Exelon - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US30161N1019
Stock: Electricity, Natural Gas, Transmission, Distribution
Total Rating 38
Risk 54
Buy Signal -0.86
| Risk 5d forecast | |
|---|---|
| Volatility | 23.6% |
| Relative Tail Risk | -3.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | 5.46 |
| Character TTM | |
|---|---|
| Beta | -0.127 |
| Beta Downside | 0.058 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.82% |
| CAGR/Max DD | 0.43 |
EPS (Earnings per Share)
Revenue
Description: EXC Exelon March 05, 2026
Exelon Corporation (EXC) is a utility services holding company.
The company distributes and transmits electricity and natural gas across the United States. This business model typically involves significant capital expenditures for infrastructure maintenance and expansion.
EXCs operations include the regulated retail sale of electricity and natural gas, as well as the transmission and distribution of these commodities. The utility sector is highly regulated, impacting pricing and operational decisions.
EXC serves a diverse customer base, including residential, commercial, industrial, public authorities, and electric railroads.
Founded in 1999 and headquartered in Chicago, Illinois, Exelon operates within the Electric Utilities GICS Sub Industry. For further detailed analysis, consider exploring ValueRays comprehensive reports.
Headlines to watch out for
- Regulated rate base growth drives stable earnings
- Energy transition investments boost infrastructure spending
- Interest rate hikes increase borrowing costs
- Weather volatility impacts energy demand
- Regulatory approvals crucial for capital projects
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 2.77b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -0.53 > 1.0 |
| NWC/Revenue: -3.24% < 20% (prev -5.33%; Δ 2.09% < -1%) |
| CFO/TA 0.05 > 3% & CFO 6.25b > Net Income 2.77b |
| Net Debt (49.40b) to EBITDA (8.79b): 5.62 < 3 |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.01b) vs 12m ago 0.70% < -2% |
| Gross Margin: 27.92% > 18% (prev 0.41%; Δ 2.75k% > 0.5%) |
| Asset Turnover: 21.62% > 50% (prev 21.37%; Δ 0.26% > 0%) |
| Interest Coverage Ratio: 2.42 > 6 (EBITDA TTM 8.79b / Interest Expense TTM 2.13b) |
Altman Z'' 0.82
| A: -0.01 (Total Current Assets 9.55b - Total Current Liabilities 10.33b) / Total Assets 116.57b |
| B: 0.06 (Retained Earnings 7.58b / Total Assets 116.57b) |
| C: 0.05 (EBIT TTM 5.14b / Avg Total Assets 112.18b) |
| D: 0.33 (Book Value of Equity 28.92b / Total Liabilities 87.77b) |
| Altman-Z'' Score: 0.82 = B |
Beneish M -2.37
| DSRI: 1.29 (Receivables 5.08b/3.75b, Revenue 24.26b/23.03b) |
| GMI: 1.46 (GM 27.92% / 40.84%) |
| AQI: 0.99 (AQ_t 0.19 / AQ_t-1 0.20) |
| SGI: 1.05 (Revenue 24.26b / 23.03b) |
| TATA: -0.03 (NI 2.77b - CFO 6.25b) / TA 116.57b) |
| Beneish M-Score: -2.37 (Cap -4..+1) = BBB |
What is the price of EXC shares?
As of March 23, 2026, the stock is trading at USD 46.44 with a total of 14,900,666 shares traded.
Over the past week, the price has changed by -7.66%, over one month by -2.83%, over three months by +7.55% and over the past year by +10.36%.
Over the past week, the price has changed by -7.66%, over one month by -2.83%, over three months by +7.55% and over the past year by +10.36%.
Is EXC a buy, sell or hold?
Exelon has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold EXC.
- StrongBuy: 4
- Buy: 2
- Hold: 9
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the EXC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.9 | 9.6% |
| Analysts Target Price | 50.9 | 9.6% |
EXC Fundamental Data Overview March 23, 2026
P/E Trailing = 17.011
P/E Forward = 16.2866
P/S = 1.9588
P/B = 1.65
P/EG = 2.8339
Revenue TTM = 24.26b USD
EBIT TTM = 5.14b USD
EBITDA TTM = 8.79b USD
Long Term Debt = 47.80b USD (from longTermDebt, last quarter)
Short Term Debt = 2.75b USD (from shortTermDebt, last quarter)
Debt = 50.55b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 49.40b USD (from netDebt column, last quarter)
Enterprise Value = 96.92b USD (47.52b + Debt 50.55b - CCE 1.15b)
Interest Coverage Ratio = 2.42 (Ebit TTM 5.14b / Interest Expense TTM 2.13b)
EV/FCF = -42.60x (Enterprise Value 96.92b / FCF TTM -2.27b)
FCF Yield = -2.35% (FCF TTM -2.27b / Enterprise Value 96.92b)
FCF Margin = -9.38% (FCF TTM -2.27b / Revenue TTM 24.26b)
Net Margin = 11.41% (Net Income TTM 2.77b / Revenue TTM 24.26b)
Gross Margin = 27.92% ((Revenue TTM 24.26b - Cost of Revenue TTM 17.48b) / Revenue TTM)
Gross Margin QoQ = -21.62% (prev 43.07%)
Tobins Q-Ratio = 0.83 (Enterprise Value 96.92b / Total Assets 116.57b)
Interest Expense / Debt = 1.08% (Interest Expense 548.0m / Debt 50.55b)
Taxrate = 17.73% (128.0m / 722.0m)
NOPAT = 4.23b (EBIT 5.14b * (1 - 17.73%))
Current Ratio = 0.92 (Total Current Assets 9.55b / Total Current Liabilities 10.33b)
Debt / Equity = 1.76 (Debt 50.55b / totalStockholderEquity, last quarter 28.80b)
Debt / EBITDA = 5.62 (Net Debt 49.40b / EBITDA 8.79b)
Debt / FCF = -21.72 (negative FCF - burning cash) (Net Debt 49.40b / FCF TTM -2.27b)
Total Stockholder Equity = 28.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.47% (Net Income 2.77b / Total Assets 116.57b)
RoE = 9.87% (Net Income TTM 2.77b / Total Stockholder Equity 28.03b)
RoCE = 6.78% (EBIT 5.14b / Capital Employed (Equity 28.03b + L.T.Debt 47.80b))
RoIC = 5.47% (NOPAT 4.23b / Invested Capital 77.31b)
WACC = 3.14% (E(47.52b)/V(98.07b) * Re(5.54%) + D(50.55b)/V(98.07b) * Rd(1.08%) * (1-Tc(0.18)))
Discount Rate = 5.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.65%
[DCF] Fair Price = unknown (Cash Flow -2.27b)
EPS Correlation: 22.05 | EPS CAGR: -2.15% | SUE: 0.47 | # QB: 0
Revenue Correlation: 64.60 | Revenue CAGR: 0.42% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=+0.000 | Chg30d=+0.004 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-12-31): EPS=2.85 | Chg7d=+0.000 | Chg30d=+0.014 | Revisions Net=+8 | Growth EPS=+3.0% | Growth Revenue=+4.1%
EPS next Year (2027-12-31): EPS=3.04 | Chg7d=+0.000 | Chg30d=+0.018 | Revisions Net=+6 | Growth EPS=+6.7% | Growth Revenue=+3.5%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 7.9% - Earnings Yield 5.9%)
[Growth] Growth Spread = -4.8% (Analyst -2.7% - Implied 2.0%)
P/E Forward = 16.2866
P/S = 1.9588
P/B = 1.65
P/EG = 2.8339
Revenue TTM = 24.26b USD
EBIT TTM = 5.14b USD
EBITDA TTM = 8.79b USD
Long Term Debt = 47.80b USD (from longTermDebt, last quarter)
Short Term Debt = 2.75b USD (from shortTermDebt, last quarter)
Debt = 50.55b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 49.40b USD (from netDebt column, last quarter)
Enterprise Value = 96.92b USD (47.52b + Debt 50.55b - CCE 1.15b)
Interest Coverage Ratio = 2.42 (Ebit TTM 5.14b / Interest Expense TTM 2.13b)
EV/FCF = -42.60x (Enterprise Value 96.92b / FCF TTM -2.27b)
FCF Yield = -2.35% (FCF TTM -2.27b / Enterprise Value 96.92b)
FCF Margin = -9.38% (FCF TTM -2.27b / Revenue TTM 24.26b)
Net Margin = 11.41% (Net Income TTM 2.77b / Revenue TTM 24.26b)
Gross Margin = 27.92% ((Revenue TTM 24.26b - Cost of Revenue TTM 17.48b) / Revenue TTM)
Gross Margin QoQ = -21.62% (prev 43.07%)
Tobins Q-Ratio = 0.83 (Enterprise Value 96.92b / Total Assets 116.57b)
Interest Expense / Debt = 1.08% (Interest Expense 548.0m / Debt 50.55b)
Taxrate = 17.73% (128.0m / 722.0m)
NOPAT = 4.23b (EBIT 5.14b * (1 - 17.73%))
Current Ratio = 0.92 (Total Current Assets 9.55b / Total Current Liabilities 10.33b)
Debt / Equity = 1.76 (Debt 50.55b / totalStockholderEquity, last quarter 28.80b)
Debt / EBITDA = 5.62 (Net Debt 49.40b / EBITDA 8.79b)
Debt / FCF = -21.72 (negative FCF - burning cash) (Net Debt 49.40b / FCF TTM -2.27b)
Total Stockholder Equity = 28.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.47% (Net Income 2.77b / Total Assets 116.57b)
RoE = 9.87% (Net Income TTM 2.77b / Total Stockholder Equity 28.03b)
RoCE = 6.78% (EBIT 5.14b / Capital Employed (Equity 28.03b + L.T.Debt 47.80b))
RoIC = 5.47% (NOPAT 4.23b / Invested Capital 77.31b)
WACC = 3.14% (E(47.52b)/V(98.07b) * Re(5.54%) + D(50.55b)/V(98.07b) * Rd(1.08%) * (1-Tc(0.18)))
Discount Rate = 5.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.65%
[DCF] Fair Price = unknown (Cash Flow -2.27b)
EPS Correlation: 22.05 | EPS CAGR: -2.15% | SUE: 0.47 | # QB: 0
Revenue Correlation: 64.60 | Revenue CAGR: 0.42% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=+0.000 | Chg30d=+0.004 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-12-31): EPS=2.85 | Chg7d=+0.000 | Chg30d=+0.014 | Revisions Net=+8 | Growth EPS=+3.0% | Growth Revenue=+4.1%
EPS next Year (2027-12-31): EPS=3.04 | Chg7d=+0.000 | Chg30d=+0.018 | Revisions Net=+6 | Growth EPS=+6.7% | Growth Revenue=+3.5%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 7.9% - Earnings Yield 5.9%)
[Growth] Growth Spread = -4.8% (Analyst -2.7% - Implied 2.0%)